InvestSMART

Elixinol Wellness Limited (ASX:EXL)

ALERT: Price-sensitive ASX Announcement for EXL
Current share price for EXL : $0.007 0 (0%)+
Announcement
Release
28 Jul 2026 8:59AM
Price at Release
$0.007
Full Release
download
Summary
In Q2 FY26, Elixinol Wellness Ltd reported a record revenue of $4.3 million, marking a 5% increase from the previous period. The company achieved a gross margin of 45% and continued to reduce its operating cost base by 23%. This quarter marked the third consecutive period of positive underlying operating cash flow, despite a net operating cash outflow of $0.58 million due to non-recurring costs and out-of-cycle payments. The Healthy Chef brand was a significant contributor, with a 20% increase in revenue, driven by e-commerce and expansion into Priceline Pharmacy. The company remained focused on high-margin products and new channel opportunities, supported by financing facilities and a cash balance of $1.0 million as of 30 June 2026. Elixinol's strategic initiatives and disciplined cost management have provided a solid foundation for sustainable growth and long-term value creation.
Key Points
  • Q2 FY26 record revenue of $4.3 million, up 5% from prior period.
  • Gross margin increased to 45%, an 8% rise from prior period.
  • Operating expenses reduced by 23% year-over-year.
  • Positive underlying operating cash flow for third consecutive quarter.
  • Healthy Chef revenue increased by 20%, driven by expansion and e-commerce.
  • Net operating cash outflow of $0.58 million due to non-recurring costs.
  • Cash balance at end of quarter was $1.0 million.
  • Continued focus on high-margin products and channel opportunities.
  • Strategic initiatives aimed at sustainable growth and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.